Stifel Financial Corp Intercept Pharmaceuticals, Inc. Transaction History

Stifel Financial Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$9.17 - $19.29 $103,290 - $217,282	11,264 New	11,264 $124,000
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $37,553 - $65,508	3,344 Added 29.47%	14,691 $203,000
Q1 2022 May 13, 2022	BUY	$13.37 - $17.79 $151,709 - $201,863	11,347 New	11,347 $185,000
Q1 2021 May 14, 2021	SELL	$19.33 - $37.75 $330,620 - $645,676	-17,104 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$24.48 - $42.47 $248,594 - $431,282	10,155 Added 146.14%	17,104 $422,000
Q3 2020 Nov 16, 2020	SELL	$39.09 - $53.44 $22,554 - $30,834	-577 Reduced 7.67%	6,949 $288,000
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $351,464 - $692,693	7,526 New	7,526 $361,000
Q1 2020 May 14, 2020	SELL	$48.35 - $118.68 $130,448 - $320,198	-2,698 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$57.36 - $124.1 $122,979 - $266,070	-2,144 Reduced 44.28%	2,698 $333,000
Q3 2019 Nov 13, 2019	BUY	$58.69 - $80.46 $284,176 - $389,587	4,842 New	4,842 $322,000
Q2 2019 Aug 14, 2019	SELL	$77.77 - $120.68 $181,126 - $281,063	-2,329 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $5,601 - $7,361	61 Added 2.69%	2,329 $258,000
Q4 2018 Feb 13, 2019	BUY	$85.79 - $126.46 $194,571 - $286,811	2,268 New	2,268 $228,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.